Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT05887817

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05887817
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05887817. Randomized; quadruple masking; primary purpose treatment. Start 2023-09-07 (actual); primary completion 2025-02-28 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
Acronym
FIVE-STAR
Condition
Chronic Kidney Diseases
Intervention (Drug)
Finerenone
Intervention (Drug)
Placebo
Lead sponsor
Saga University (class: other)

Record details

Record id
cardio:ct-nct05887817
Content hash
e9e2701ecf2d24fd29b63e027b7d947128b4dead3fe4c8d69e603c091c4b4898